(4S,7S,10R,11S,12S)-12-[(1R)-1-hydroxyethyl]-10-methyl-17,21-dioxa-8-thia-2,5,14-triazapentacyclo[21.3.1.1^{4,7}.0^{9,15}.0^{11,14}]octacosa-1(27),9(15),23,25-tetraene-3,13,16,22-tetrone

ID: ALA2431071

PubChem CID: 73347804

Max Phase: Preclinical

Molecular Formula: C25H29N3O7S

Molecular Weight: 515.59

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](O)[C@H]1C(=O)N2C3=C(S[C@@H]4CN[C@@H](C4)C(=O)Nc4cccc(c4)C(=O)OCCCOC3=O)[C@H](C)[C@H]12

Standard InChI:  InChI=1S/C25H29N3O7S/c1-12-19-18(13(2)29)23(31)28(19)20-21(12)36-16-10-17(26-11-16)22(30)27-15-6-3-5-14(9-15)24(32)34-7-4-8-35-25(20)33/h3,5-6,9,12-13,16-19,26,29H,4,7-8,10-11H2,1-2H3,(H,27,30)/t12-,13-,16+,17+,18-,19-/m1/s1

Standard InChI Key:  HFFBFNZMWTYVKV-CELYIQNJSA-N

Molfile:  

     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
    7.2900  -15.1853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0737  -15.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4606  -15.1936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5547  -14.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2858  -14.3684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4523  -14.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0654  -14.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3308  -16.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8521  -11.9181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3799  -14.7707    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.6317  -13.0147    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8549  -12.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5669  -11.5061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0205  -13.9658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8759  -15.7742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0090  -13.1393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3642  -13.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8402  -14.0773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7557  -13.9371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2832  -11.9112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2926  -12.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1365  -11.5072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7875  -16.8357    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7297  -14.3751    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6244  -13.8370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4381  -16.6614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3080  -14.3820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3183  -13.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7806  -13.1120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7193  -12.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7135  -11.8944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9936  -11.4914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0300  -14.3228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1297  -13.3807    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.5832  -14.8548    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.3123  -15.2031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4266  -15.5877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3719  -16.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4382  -14.8788    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   10.6713  -12.1599    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  1  1  0
  6  5  1  0
  7  5  1  0
  8  2  1  0
 12  9  1  0
 10  4  1  0
 11 25  1  0
 12 17  1  0
 13  9  1  0
 14 16  1  0
 15  3  2  0
 16 21  1  0
 17 18  1  0
 18 10  1  0
 19  6  1  0
 20 13  1  0
 21 20  2  0
 22  9  2  0
 23  8  2  0
 24 14  2  0
 25 18  1  0
 26  8  1  0
 27 14  1  0
  7 28  1  1
 19 29  1  1
 30 31  1  0
 31 32  2  0
 32 20  1  0
 33 19  1  0
  5 34  1  6
  6 35  1  1
  4  7  1  0
  6  3  1  0
 11 12  1  0
 16 30  2  0
 27 36  1  0
 36 37  1  0
 37 38  1  0
 38 26  1  0
 18 39  1  6
 12 40  1  6
M  END

Associated Targets(Human)

Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 515.59Molecular Weight (Monoisotopic): 515.1726AlogP: 1.26#Rotatable Bonds: 1
Polar Surface Area: 134.27Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.98CX Basic pKa: 8.99CX LogP: -0.02CX LogD: -1.61
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: 0.74

References

1. Singh SB, Rindgen D, Bradley P, Cama L, Sun W, Hafey MJ, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll R, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2013)  Design, synthesis, and evaluation of prodrugs of ertapenem.,  (8): [PMID:24900737] [10.1021/ml400092n]
2. Singh SB, Rindgen D, Bradley P, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll RM, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2014)  Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugs.,  57  (20): [PMID:25265501] [10.1021/jm500879a]

Source